Joint Corp Q3: Net Loss of $117K as Refranchising Charges Offset Franchise Profit
JYNT is trading near its 52-week low of $6.79 (0.6% below the low).
Summary
Joint Corp's Q3 10-Q confirms the already-reported $13.55M revenue and guidance cut, and shows a $117,360 net loss after $2.08M of refranchising impairment charges. Cash dropped to $18.3M, and the company paid $8.0M in October to reacquire Texas regional developer rights.
Key Events · Earnings and Guidance · JYNT
-
Q3 Swings to Net Loss
Net loss of $117,360 versus net income of $855,009 a year earlier, as a $1.57M loss from discontinued operations offset $1.46M of income from continuing franchise operations.
-
Impairment Charges Hit Discontinued Ops
Discontinued operations recorded $2.08M of net loss on disposition or impairment in Q3, including $1.08M of impairment on assets held for sale.
-
Cash Falls After Buybacks
Cash and equivalents were $18.3M at September 30, 2026, down from $23.6M at December 31, 2025, after $5.6M of share repurchases under the 2025 SRP.
-
$8.0M Texas Rights Buyback
On October 1, 2026 the company paid $8.0M in cash to reacquire Texas regional developer rights covering 141 franchised clinics, with up to $2.0M more contingent on gross sales metrics over two annual periods.
Analysis · JYNT · Real Estate & Construction
The headline numbers were already out on November 5: Q3 revenue of $13.55M and a guidance cut to $508M-$512M in 2026 system-wide sales. What the 10-Q adds is the balance sheet behind them. Continuing franchise operations earned $1.46M, but a $1.57M loss from the clinics being sold — including $2.08M of disposition and impairment charges — pushed the quarter to a $117,360 net loss. Cash fell to $18.3M from $23.6M at year-end after $5.6M of buybacks, and the company then spent $8.0M in cash on October 1 to buy back the Texas regional developer rights, with up to $2.0M more contingent on sales targets. That is a meaningful draw on liquidity at a moment when system-wide sales are declining, which is why the board added $5.0M to the repurchase authorization on November 3.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, JYNT was trading at $6.75 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $104.2M. The 52-week trading range was $6.79 to $10.67. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.